-
At JP Morgan, Myriad Genetics Says Q4 Test Volumes Disappointing, Firm Preps New Launches in 2025
16 Jan 2025 05:34 GMT
… Healthcare Conference here on Wednesday, Myriad Genetics CEO Paul Diaz provided preliminary … $1.56 per share.
Adjusted earnings per share for Q4 will …
-
Myriad Genetics Reports Preliminary Q4 Results; Issues 2025 Outlook
15 Jan 2025 18:43 GMT
Myriad Genetics (MYGN) reported preliminary results for … million.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews …
-
Myriad Genetics Announces Select Preliminary Fourth Quarter and Full Year 2024 Financial Results and Introduces Full Year 2025 Financial Guidance
15 Jan 2025 13:30 GMT
… this press release. About Myriad Genetics
Myriad Genetics is a leading genetic … income (loss) or earnings per share because it cannot … .66
)
$
(1.56
)
Adjusted Earnings Per Share
Basic … .
(3) To determine Adjusted Earnings (Loss) Per Share, or …
-
Myriad Genetics Provides Update on Discussions with UnitedHealthcare regarding Medical Policy for Pharmacogenetic Testing
10 Dec 2024 23:26 GMT
… .” During Myriad’s third quarter earnings call held on November 6 …
The GeneSight Psychotropic test from Myriad Genetics is the category-leading pharmacogenomic … more at GeneSight.com. About Myriad Genetics
Myriad Genetics is a leading genetic testing …
-
Myriad Genetics, Inc. (NASDAQ:MYGN) Q3 2024 Earnings Call Transcript
11 Nov 2024 13:36 GMT
Myriad Genetics, Inc. (NASDAQ:MYGN) Q3 2024 Earnings Call Transcript November 9, … and welcome to the Myriad Genetics third quarter 2024 earnings call. During the … , everybody.
Follow Myriad Genetics Inc (NASDAQ:MYGN) Follow Myriad Genetics Inc (NASDAQ:MYGN …
-
Myriad Genetics Reports Third Quarter 2024 Financial Results; Updates 2024 Financial Guidance
07 Nov 2024 21:05 GMT
… of 2023; adjusted earnings (loss) per share … 843 million, and adjusted earnings per share (EPS) … myriad.com. About Myriad Genetics
Myriad Genetics is a leading … Prequel, SneakPeek
Pharmacogenomics – GeneSight
MYRIAD GENETICS, INC.
AND SUBSIDIARIES
Condensed …
-
Myriad Genetics Comments On Unitedhealthcare’S Updated Medical Policy For Pharmacogenetic Testing
04 Nov 2024 14:16 GMT
… hold its third quarter 2024 earnings conference call after the market …
The GeneSight Psychotropic test from Myriad Genetics is the category-leading pharmacogenomic … more at GeneSight.com . About Myriad Genetics
Myriad Genetics is a leading genetic testing …
-
Myriad Genetics Comments on UnitedHealthcare’s Updated Medical Policy for Pharmacogenetic Testing
04 Nov 2024 13:39 GMT
… hold its third quarter 2024 earnings conference call after the market …
The GeneSight Psychotropic test from Myriad Genetics is the category-leading pharmacogenomic … more at GeneSight.com. About Myriad Genetics
Myriad Genetics is a leading genetic testing …
-
Myriad Genetics to Release Third Quarter 2024 Financial Results on November 7, 2024
30 Oct 2024 12:00 GMT
… will hold its third quarter earnings conference call on Thursday, … The company’s quarterly earnings will be released the … live webcast of the earnings conference call can be … investor.myriad.com. About Myriad Genetics
Myriad Genetics is a leading genetic …
-
Myriad Genetics Q2 Earnings Surpass, '24 Outlook Raised
08 Aug 2024 15:37 GMT
Myriad Genetics, Inc. MYGN reported adjusted earnings of 5 cents per share … EPS Surprise
Myriad Genetics, Inc. price-consensus-eps-surprise-chart | Myriad Genetics, Inc. … 12%.
Our Take
Myriad Genetics delivered better-than-expected earnings and revenues in …
About
© 1995-2025